Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: KonKilo who wrote (15746)	5/7/1998 11:15:00 PM
From: Popiye	Read Replies (2) \| Respond to of 34592

Interesting.. never heard of HYALF.. their patient deals with medicine relating to sun-spot cancer. Their listing in Europe, three countries do not get sun, two do-Italy and France. I have a friend in Australia that has told me many times the issues with the ozone depletion in Australia and the kids can not go out doors for any length of time without their heads and bodies covered due to the sun. So - do they or is their competition or other patients involving this issue? Their loans really suck= 12% and they converted money to .2526 per share. Looks like maybe next year with approvals in other countries and in the usa they could sell their medicine. Best wishes:)